Zevra Therapeutics, Inc.
ZVRA
$9.98
-$0.21-2.01%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -4.26% | -1.53% | 223.50% | -9.88% | -22.24% |
| Total Receivables | 38.10% | -7.80% | 44.77% | 20.06% | 34.90% |
| Inventory | 27.29% | 23.38% | -56.70% | 29.90% | -- |
| Prepaid Expenses | -5.41% | 69.99% | 15.56% | -7.06% | 78.03% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -0.94% | -0.54% | 177.47% | -5.18% | -13.49% |
|
|
|||||
| Total Current Assets | -0.94% | -0.54% | 177.47% | -5.18% | -13.49% |
| Net Property, Plant & Equipment | -6.79% | -12.89% | 1.80% | 103.16% | -29.01% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -4.69% | -4.48% | -89.53% | -2.34% | -2.29% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 17.07% | -12.87% | -90.81% | -4.17% | 22.82% |
| Total Assets | 5.41% | 5.40% | 48.39% | -3.04% | -7.01% |
|
|
|||||
| Total Accounts Payable | -77.62% | -30.11% | -11.09% | 36.28% | -46.55% |
| Total Accrued Expenses | 279.89% | 0.18% | 8.36% | -71.78% | 114.23% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -4.99% | -16.00% | -10.87% | 40.24% | -22.22% |
| Total Finance Division Other Current Liabilities | 67.65% | 30.94% | 101.88% | 50.49% | 143.01% |
| Total Other Current Liabilities | 67.65% | 30.94% | 101.88% | 50.49% | 143.01% |
| Total Current Liabilities | 50.42% | -9.43% | 6.88% | -20.81% | -1.21% |
|
|
|||||
| Total Current Liabilities | 50.42% | -9.43% | 6.88% | -20.81% | -1.21% |
| Long-Term Debt | 1.01% | 1.02% | 1.00% | 0.98% | 1.02% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -11.08% | -8.78% | -8.55% | 211.29% | -22.98% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -42.32% | 0.20% | 11.51% | -2.38% | 59.50% |
| Total Liabilities | -5.02% | -1.51% | 5.59% | -4.89% | 13.70% |
|
|
|||||
| Common Stock & APIC | 1.32% | 2.92% | 0.69% | 0.93% | 0.89% |
| Retained Earnings | 2.80% | -0.13% | 14.69% | -0.61% | -7.61% |
| Treasury Stock & Other | 12.33% | 0.09% | -21.20% | -6.89% | 6.72% |
| Total Common Equity | 16.14% | 13.59% | 185.77% | 3.42% | -43.15% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 16.14% | 13.59% | 185.77% | 3.42% | -43.15% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 16.14% | 13.59% | 185.77% | 3.42% | -43.15% |
|
|
|||||